DNA delivery from polymer matrices for tissue engineering

  • An Erratum to this article was published on 01 August 1999

Abstract

We have proposed engineering tissues by the incorporation and sustained release of plasmids encoding tissue-inductive proteins from polymer matrices. Matrices of poly(lactide-co-glycolide) (PLG) were loaded with plasmid, which was subsequently released over a period ranging from days to a month in vitro. Sustained delivery of plasmid DNA from matrices led to the transfection of large numbers of cells. Furthermore, in vivo delivery of a plasmid encoding platelet-derived growth factor enhanced matrix deposition and blood vessel formation in the developing tissue. This contrasts with direct injection of the plasmid, which did not significantly affect tissue formation. This method of DNA delivery may find utility in tissue engineering and gene therapy applications.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: (A) Cross-sectional view of 75:25 PLG sponge fabricated with the gas foaming procedure and (B) the cumulative release of plasmid DNA from 75:25 (i.v. = 0.2) (), 85:15 (i.v. = 0.7) (□), and 75:25 (i.v. = 0.7) (░) PLG.
Figure 2: In vitro transfection by plasmid DNA released at different times from the polymer sponge.
Figure 3: Photomicrograph of a cross section of tissue containing polymer matrix loaded with nt β-gal, which was retrieved four weeks after implantation.
Figure 4: In vivo response to release of plasmids encoding for PDGF and control (nt β-gal) at two and four weeks.

References

  1. 1

    Langer, R. & Vacanti, J.P. Tissue engineering. Science 260, 920–926 ( 1993).

  2. 2

    Kim, B.S. & Mooney, D.J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol. 16, 224–230 ( 1998).

  3. 3

    Mooney, D.J. et al. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J. Biomed. Mater. Res. 37, 413–420 (1997).

  4. 4

    Deuel, T.F. in: Principles of tissue engineering (eds Lanza, R.P., Langer, R. & Chick W.L.) 133–150 (Academic, San Diego, 1997).

  5. 5

    Langer, R. New methods of drug delivery. Science 249, 1527–1533 (1992).

  6. 6

    Jong, Y.S. et al. Controlled release of plasmid DNA. J. Cont. Rel. 47 , 123–134 (1997) [Not In Index Medicus Please Spell Out].

  7. 7

    Labhasetwar, V., Bonadio, J., Goldstein, S., Chen, W. & Levy, R.J. A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle. J. Pharm. Sci. 87, 1347–1350 (1998).

  8. 8

    Ledley, F.D. Pharmaceutical approach to somatic gene therapy. Pharm. Res. 13, 1595–1614 (1996).

  9. 9

    Giannobile, W.V. Periodontal tissue engineering by growth factors. Bone 19, 23S–37S (1996).

  10. 10

    Harris, L.D., Kim, B.S. & Mooney, D.J. Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mat. Res. 42, 396– 402 (1998).

  11. 11

    Wong, W.H. & Mooney D.J. in Synthetic biodegradable polymer scaffolds (eds Atala, A. & Mooney, D.J.) 51– 82 (Birkhausen, Boston; 1997).

  12. 12

    Raines, E.W. & Ross, R. in Biology of platelet-derived growth factor (eds Westermark, B. & Sorg, C.) 74– 114 (Karger, Switzerland; 1993).

  13. 13

    Peters, M.C. & Mooney, D.J. in Tissue engineering for therapeutic use 2. (eds Ikada, Y. & Enomoto, S.) 55–65 (Elsevier, Amsterdam; 1998).

  14. 14

    Langer, R. Drug delivery and targeting. Nature 392S, 5–10 (1998).

  15. 15

    Hedley, M.L. Curley, J. & Urban, R. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. 4, 365–368 (1998).

  16. 16

    Nor, J.E., Christensen, J., Mooney, D.J. & Polverini, P. VEGF enhances the survival of endothelial cells and sustains angiogenesis by inducing expression of Bcl-2. Am. J. Pathol. 154 , 375–384 (1999).

  17. 17

    Stein, G.S., Lian, J.B., Stein, J.L., Van Wijnen, A.J. & Montecino, M. Transcriptional control of osteoblast growth and differentiation. Physiol. Rev. 76, 593– 629 (1996).

  18. 18

    Fang, J. et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Nat. Acad. Sci.USA 93, 5753–5758 (1996).

Download references

Acknowledgements

The authors gratefully acknowledge technical assistance from Jeremy Blum and Elly Liao. Financial support for this work was provided by National Institutes of Health grant 1RO1DE13004, Reprogenesis, and Selective Genetics. L.D.S. was supported by National Institute of Dental Researchtraining grant DE07057.

Author information

Correspondence to David J. Mooney.

Rights and permissions

Reprints and Permissions

About this article

Further reading